HucMDE-treated T2DM rats and L-O2 cells had higher expression levels of glycolytic enzymes and p-GSK3β/GSK3β, whereas hepatic gluconeogenic enzymes were decreased compared with those in the T2DM and PA-treated groups (Fig. 2a–c, f–h). The gene discussed is GSK3B; the disease is type 2 diabetes mellitus.